EVH News and Press, Evolent Health Inc Class A From 05/09/24

Evolent Announces First Quarter 2024 Results PR Newswire Revenue of $639.7 million , an increase of $212.0 million or 49.6%, from the three months ended March 31, 2023 . Net loss attributable to common shareholders of Evolent Health, Inc. of $(25.2) mil...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...

2024-05-08 17:20:09 ET More on Evolent Health Evolent Health, Inc. (EVH) Q4 2023 Earnings Call Transcript Evolent Health Q4 2023 Earnings Preview Engaged Capital adds Nevro, PRA Group; exits Primo Water Seeking Alpha’s Quant Rating on Evolent Health ...

2024-04-19 10:47:02 ET Intel Corp. (INTC) INTC is trading DOWN for the last 4 days, and it at trading at $34.86 with volume of 14,560,236 and a one day change of $-0.18 (-0.51%). Intel Corp. has a 52-week low of 26.86 and a 52-week high of $51.28. The business's 50-day moving averag...

Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 PR Newswire Company to Participate in Upcoming Conferences WASHINGTON , April 18, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better ...

2024-04-17 14:30:04 ET Piper Sandler analyst issues OVERWEIGHT recommendation for EVH on April 17, 2024 12:15PM ET. The previous analyst recommendation was Overweight. EVH was trading at $29.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-04-01 10:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-09 04:50:41 ET Summary Health Catalyst reported strong Q4 results, meeting guidance and showing growth in technology and professional services revenue. The drop in HCAT's share price presents a buying opportunity, as the company's growth initiatives, such as its TEMS offer...

2024-02-23 14:58:37 ET More on Evolent Health Evolent Health Q4 2023 Earnings Preview Engaged Capital adds Nevro, PRA Group; exits Primo Water Seeking Alpha’s Quant Rating on Evolent Health Historical earnings data for Evolent Health Read the...

2024-02-23 01:15:27 ET Image source: The Motley Fool. Evolent Health (NYSE: EVH) Q4 2023 Earnings Call Feb 22, 2024 , 5:00 p.m. ET Operator Continue reading For further details see: Evolent Health (EVH) Q4 2023 Earnings Call Transcript